Abdominal ImagingArchives
Machine learning-based differentiation of benign and malignant adrenal lesions using 18F-FDG PET/CT: a two-stage classification and SHAP interpretation study
Abdominal Imaging 10 min.
Adrenal lesions are frequently encountered in oncology imaging, particularly in patients with known malignancies. Approximately 50% of adrenal masses identified in individuals with extra-adrenal primary malignancies represent metastases, while benign adrenal lesions may coexist in patients with malignancy,...
A contrast‑enhanced CT histogram‑driven nomogram for predicting post‑radiotherapy liver regeneration in hepatocellular carcinoma
Abdominal Imaging 6 min.
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide [1]. Radical hepatic resection is the standard curative treatment for early-stage HCC; however, many patients present with high-risk pathological features such as narrow surgical margins (< 1 cm) or microvascular...
Assessment of tertiary lymphoid structures via 18F-FDG PET/CT scan in patients with pancreatic adenocarcinoma
Abdominal Imaging 8 min.
Pancreatic adenocarcinoma (PAAD) is one of the most common malignancies and ranks as the sixth leading cause of cancer-related mortality [1]. Most PAAD patients are diagnosed at an advanced stage owing to the absence of timely diagnosis and typical symptoms at an early stage, resulting in an overall...
Head-to-head comparison of [18F] fluorodeoxyglucose PET/CT and [68Ga]Ga-prostate specific membrane antigen-11 PET/CT in radioactive iodine refractory differentiated thyroid cancer.
Abdominal Imaging 1 min.
Radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) is associated with challenges in both imaging and treatment due to resistance to I-131. The aim of this study is to compare the lesion detection rates of [18F] fluorodeoxyglucose (FDG) PET/computed tomography [CT] and [68Ga]Ga-prostate...
